It is an honor for me to lead Pfizer at this important time for both our company and the industry. I’ve spent my entire career at Pfizer and during this time I have seen the industry change and evolve in terms of customers’ needs, regulatory standards and where growth occurs. Among these changes, one of the most important has been the increasing pressure from payers, governments and society to deliver greater value. That’s why I believe there is a fundamental question facing the industry and Pfizer. Simply stated, it is: Do we have a research model that will consistently produce results that improve the lives of patients These encompass environmental sustainability, investments in treatments for neglected diseases and improvement in access to medicines. Robust Sales, Wider Scope, Important Partnerships We have been working to increase Pfizer’s product mix and geographic presence. In 2010 Pfizer had 15 brands that surpassed the $1 billion mark in sales, a record for our industry. Growth in our patented portfolio was driven by important medicines such as Sutent, Lyrica, Prevnar and Enbrel. We widened our geographic scope with a focus on emerging markets, where half of the world’s population lives and where there is rising economic wealth. In 2010 our Biopharmaceutical revenues in emerging markets exceeded $8.5 billion,3 up 41 percent over 2009, and, for the first time, we achieved more than $1 billion of annual revenue in both China and Brazil. During 2010 close interaction among our development, medical, external affairs and commercialization teams helped boost registrations for Prevnar 134 for pediatric use to more than 80 countries and launches to more than 55 countries. This new vaccine, which helps
eliminate gaps to achieve statement objective goals (Thompson & Strickland, 2013). Pfizer, Inc. Company History Pfizer, Inc. is the world leader and manufacturer of pharmaceutical products (Fortune, 2013). In 1849, with $2,500 borrowed funds, Charles Pfizer, a Chemist, and Charles Erhart, a confectioner, started (formerly known as) Charles Pfizer & Company in Brooklyn, NY. The following are historical facts about Pfizer: • 1849 – 1899: The organization’s first product, an antiparasitic, was created…
Company Overview: Pfizer is an international pharmaceutical company and is considered one of the leading companies in this industry with Lipitor and Viagra as its most known manufactured drugs. The company grew from a one building medicine manufacturer to a multinational company running its operations all over the world. In addition, the mergers and acquisitions that the business went through ensured that Pfizer name is associated with any global resource specialized in health and well-being industry…
PFIZER INC. Pfizer Strategic Plan Date Submitted: May 25, 2005 Pfizer's Strategic Plan: Overview Executive Summary Pfizer is a New York City based major drug producer, ranking first in pharmaceutical sales in the U.S., with 2005 revenues of 56.7 billion. With almost 60 billion in Revenue, Pfizer remains the industry's behemoth, overseeing the most ambitious research agenda for any company in the world. Pfizer's is spending on R&D supports 12,000 scientists. Pfizer's research increased 3…
Macroeconomic Forecast Pfizer, Inc. March 14, 2005 Abstract This paper is a Macroeconomic Forecast Outline of Pfizer, Inc. This outline will identify main economic indicators for Pfizer as a business entity and as a representative of pharmaceutical industry. This paper will identify sources of various data collected based on economical activity and relationships between different economical indicators. Main Economic Indicators The purpose of economic indicators is to provide for researchers…
Pfizer and Thailand’s Tug of War: Containing the Threat of Compulsory Licenses INTS 721: International Political Economy of Business Environments Associate Professor Witold Jerzy Henisz Hans Battle Victor Petenkemani Robert Sammon Jonathan Taqqu Executive Summary: Since the late 1990’s, developing nations have become increasingly skilled at using the threat of issuing compulsory licenses to extract lower prices on patented medicines from western pharmaceutical companies. In early 2007, Thailand’s…
Evaluate 6.1, Branding Dennis McKeon Southern New Hampshire University Abstract This document will discuss the marketing theorem: Successful brands are built on successful products. I agree with the theorem that successful brands are built on successful products entirely for some product categories but partially for others. Products…
to apply the Framers’ original intent, whilst some see the Constitution as a living document that changes over time. Judicial review- this is the precedent which allows Justices to declare laws as unconstitutional. This precedent was established by Marbury vs Madison 1803, allowing the power of the judicial branch to grow over time. Some examples of judicial review are Roe v. Wade, (1973), in which the Court overturned a Texas law prohibiting abortion; Brown v. Board of Education, (1954), in which…
Drugging America Ed pawluk Yearbook IDC 4UT/OU Friday may 6, 2011 Drugs are defined as “a chemical substance used in the treatment, cure, prevention or diagnosis of disease or used to otherwise enhance physical or mental well-being.”(Dictionary.refferance.com) Drugs have a long history as they have been around longer than man-kind; in their plant forms, even before we knew the consequences of use and side effects on the human body. Drug-related incidents have taken more human lives than have…
Cialis Harvard Business Review Case Study The most relevant dimensions among which to segment the patient market for ED are the patients who would be interested in a medication for ED, the patients who would or would not come forward to talk to their health care provider and ask them about ED and what options there are to treat it, the patients who have health conditions that would not let them use a medication for ED, the patients who are unaware that there are options available for treating ED…